This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-148a-3p | A4GNT | -0.75 | 0 | -1.24 | 0.00042 | MirTarget | -0.73 | 0 | NA | |
2 | hsa-miR-148a-5p | ABCB5 | -0.77 | 0 | 1.74 | 1.0E-5 | mirMAP | -0.57 | 0 | NA | |
3 | hsa-miR-148a-5p | ABCC5 | -0.77 | 0 | 1.23 | 0 | mirMAP | -0.21 | 0 | NA | |
4 | hsa-miR-148a-5p | ABI2 | -0.77 | 0 | 0.14 | 0.17339 | miRNATAP | -0.24 | 0 | NA | |
5 | hsa-miR-148a-3p | ACHE | -0.75 | 0 | 0.07 | 0.84522 | miRNATAP | -0.64 | 0 | NA | |
6 | hsa-miR-148a-3p | ACSL4 | -0.75 | 0 | 2.07 | 0 | miRNATAP | -0.65 | 0 | NA | |
7 | hsa-miR-148a-5p | ACTG1 | -0.77 | 0 | -0.12 | 0.20938 | MirTarget; miRNATAP | -0.17 | 0 | NA | |
8 | hsa-miR-148a-5p | ACTR3 | -0.77 | 0 | 0.05 | 0.43435 | mirMAP | -0.12 | 0 | NA | |
9 | hsa-miR-148a-3p | ACVR1 | -0.75 | 0 | -0.44 | 1.0E-5 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.13 | 0.0001 | NA | |
10 | hsa-miR-148a-3p | ADAM10 | -0.75 | 0 | -0 | 0.9783 | MirTarget | -0.11 | 0.02275 | NA | |
11 | hsa-miR-148a-3p | ADAM19 | -0.75 | 0 | -0.32 | 0.02321 | mirMAP | -0.33 | 0 | NA | |
12 | hsa-miR-148a-3p | ADAM22 | -0.75 | 0 | 1.17 | 0.00038 | MirTarget; miRNATAP | -0.57 | 0 | NA | |
13 | hsa-miR-148a-3p | ADAM23 | -0.75 | 0 | 1.53 | 0.00013 | MirTarget | -0.47 | 0.00032 | NA | |
14 | hsa-miR-148a-3p | ADAMTS15 | -0.75 | 0 | -0.88 | 0.00206 | MirTarget; miRNATAP | -0.41 | 1.0E-5 | NA | |
15 | hsa-miR-148a-5p | ADAMTS15 | -0.77 | 0 | -0.88 | 0.00206 | mirMAP | -0.4 | 1.0E-5 | NA | |
16 | hsa-miR-148a-3p | ADAMTS18 | -0.75 | 0 | 1.44 | 1.0E-5 | miRNATAP | -0.21 | 0.04667 | NA | |
17 | hsa-miR-148a-3p | ADAMTS5 | -0.75 | 0 | -0.16 | 0.36499 | miRNATAP | -0.31 | 0 | NA | |
18 | hsa-miR-148a-5p | ADAMTS5 | -0.77 | 0 | -0.16 | 0.36499 | mirMAP; miRNATAP | -0.31 | 0 | NA | |
19 | hsa-miR-148a-3p | ADM2 | -0.75 | 0 | 1.72 | 0 | mirMAP | -0.43 | 0 | NA | |
20 | hsa-miR-148a-3p | ADPRH | -0.75 | 0 | -0.13 | 0.2674 | MirTarget | -0.25 | 0 | NA | |
21 | hsa-miR-148a-5p | ADSS | -0.77 | 0 | 0.31 | 0.00033 | MirTarget | -0.11 | 4.0E-5 | NA | |
22 | hsa-miR-148a-5p | AGPAT4 | -0.77 | 0 | 0.87 | 7.0E-5 | mirMAP | -0.25 | 0.00016 | NA | |
23 | hsa-miR-148a-3p | AHDC1 | -0.75 | 0 | -0.23 | 0.02626 | miRNATAP | -0.12 | 0.00053 | NA | |
24 | hsa-miR-148a-5p | ALPK3 | -0.77 | 0 | 1.32 | 0 | mirMAP | -0.3 | 0.00022 | NA | |
25 | hsa-miR-148a-3p | AMZ1 | -0.75 | 0 | -1.28 | 0.00014 | mirMAP | -0.44 | 6.0E-5 | NA | |
26 | hsa-miR-148a-3p | ANK2 | -0.75 | 0 | -0.94 | 8.0E-5 | MirTarget; miRNATAP | -0.44 | 0 | NA | |
27 | hsa-miR-148a-5p | ANK2 | -0.77 | 0 | -0.94 | 8.0E-5 | MirTarget; miRNATAP | -0.3 | 4.0E-5 | NA | |
28 | hsa-miR-148a-3p | ANKRD27 | -0.75 | 0 | 0.9 | 0 | mirMAP | -0.18 | 0 | NA | |
29 | hsa-miR-148a-3p | ANKRD52 | -0.75 | 0 | 1.46 | 0 | mirMAP; miRNATAP | -0.25 | 0 | NA | |
30 | hsa-miR-148a-5p | ANKRD52 | -0.77 | 0 | 1.46 | 0 | miRNATAP | -0.2 | 0 | NA | |
31 | hsa-miR-148a-3p | ANKS6 | -0.75 | 0 | 0.76 | 0.01521 | mirMAP | -0.63 | 0 | NA | |
32 | hsa-miR-148a-3p | ANXA4 | -0.75 | 0 | -0.2 | 0.167 | MirTarget | -0.36 | 0 | NA | |
33 | hsa-miR-148a-3p | ARAP2 | -0.75 | 0 | -1.13 | 0 | MirTarget | -0.26 | 0 | NA | |
34 | hsa-miR-148a-5p | ARHGAP31 | -0.77 | 0 | -0.42 | 0.00347 | mirMAP | -0.14 | 0.00129 | NA | |
35 | hsa-miR-148a-3p | ARHGEF17 | -0.75 | 0 | 0.06 | 0.69914 | miRNATAP | -0.46 | 0 | NA | |
36 | hsa-miR-148a-5p | ARHGEF18 | -0.77 | 0 | 0.5 | 0 | MirTarget; miRNATAP | -0.12 | 0 | NA | |
37 | hsa-miR-148a-5p | ARID5B | -0.77 | 0 | -0.52 | 0.00012 | mirMAP | -0.17 | 3.0E-5 | NA | |
38 | hsa-miR-148a-5p | ASAH1 | -0.77 | 0 | -0.44 | 0.00056 | MirTarget; miRNATAP | -0.22 | 0 | NA | |
39 | hsa-miR-148a-3p | ATG4D | -0.75 | 0 | 0.24 | 0.03588 | MirTarget | -0.18 | 0 | NA | |
40 | hsa-miR-148a-3p | ATP11A | -0.75 | 0 | 0.19 | 0.15998 | MirTarget | -0.17 | 0.00011 | NA | |
41 | hsa-miR-148a-3p | ATP2B4 | -0.75 | 0 | 0.27 | 0.06736 | MirTarget; miRNATAP | -0.11 | 0.02111 | NA | |
42 | hsa-miR-148a-3p | ATP7A | -0.75 | 0 | 0.25 | 0.01885 | MirTarget; miRNATAP | -0.12 | 0.00074 | NA | |
43 | hsa-miR-148a-3p | AURKB | -0.75 | 0 | 3.49 | 0 | miRNAWalker2 validate | -0.53 | 0 | NA | |
44 | hsa-miR-148a-3p | B4GALT2 | -0.75 | 0 | 0.26 | 0.00786 | miRNATAP | -0.13 | 3.0E-5 | NA | |
45 | hsa-miR-148a-3p | B4GALT5 | -0.75 | 0 | -0.52 | 0 | MirTarget; miRNATAP | -0.33 | 0 | NA | |
46 | hsa-miR-148a-3p | BAZ2A | -0.75 | 0 | 0.46 | 0 | mirMAP; miRNATAP | -0.15 | 0 | NA | |
47 | hsa-miR-148a-3p | BCL2 | -0.75 | 0 | -0.35 | 0.02497 | miRNAWalker2 validate; miRTarBase | -0.31 | 0 | 21455217; 23975374 | MiR 148a promotes apoptosis by targeting Bcl 2 in colorectal cancer;MiR 148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl 2; Using western blot and luciferase activity assay CCKBR and Bcl-2 were identified as targets of miR-148a; Moreover we also found that the expression of Bcl-2 lacking in 3'UTR could abrogate the pro-apoptosis function of miR-148a |
48 | hsa-miR-148a-3p | BCL9L | -0.75 | 0 | 0.49 | 7.0E-5 | mirMAP | -0.25 | 0 | NA | |
49 | hsa-miR-148a-5p | BDNF | -0.77 | 0 | 0.05 | 0.83189 | mirMAP | -0.26 | 0.00044 | NA | |
50 | hsa-miR-148a-3p | BHLHE41 | -0.75 | 0 | -0.4 | 0.15906 | MirTarget | -0.82 | 0 | NA | |
51 | hsa-miR-148a-5p | BICD1 | -0.77 | 0 | 0.8 | 0.0004 | mirMAP | -0.4 | 0 | NA | |
52 | hsa-miR-148a-3p | BMF | -0.75 | 0 | 0.48 | 0.01823 | mirMAP | -0.31 | 0 | NA | |
53 | hsa-miR-148a-3p | BTBD10 | -0.75 | 0 | 0.28 | 2.0E-5 | MirTarget; miRNATAP | -0.17 | 0 | NA | |
54 | hsa-miR-148a-3p | BTBD3 | -0.75 | 0 | 0.3 | 0.00861 | miRNAWalker2 validate; miRNATAP | -0.17 | 1.0E-5 | NA | |
55 | hsa-miR-148a-3p | C1orf116 | -0.75 | 0 | -1.07 | 0.0053 | mirMAP | -0.61 | 0 | NA | |
56 | hsa-miR-148a-5p | C3orf14 | -0.77 | 0 | -0.24 | 0.47117 | mirMAP | -0.29 | 0.00417 | NA | |
57 | hsa-miR-148a-5p | C5AR1 | -0.77 | 0 | -1.17 | 0 | mirMAP | -0.18 | 0.00087 | NA | |
58 | hsa-miR-148a-3p | C5orf30 | -0.75 | 0 | 0.91 | 0.00049 | miRNATAP | -0.74 | 0 | NA | |
59 | hsa-miR-148a-5p | CA12 | -0.77 | 0 | 2.34 | 0 | MirTarget | -0.98 | 0 | NA | |
60 | hsa-miR-148a-5p | CACNA1D | -0.77 | 0 | 0.08 | 0.77567 | MirTarget; miRNATAP | -0.49 | 0 | NA | |
61 | hsa-miR-148a-3p | CACNA1E | -0.75 | 0 | 1.61 | 4.0E-5 | mirMAP | -0.55 | 2.0E-5 | NA | |
62 | hsa-miR-148a-5p | CACNA1E | -0.77 | 0 | 1.61 | 4.0E-5 | mirMAP | -0.5 | 3.0E-5 | NA | |
63 | hsa-miR-148a-3p | CASZ1 | -0.75 | 0 | 0.04 | 0.75925 | miRNATAP | -0.22 | 0 | NA | |
64 | hsa-miR-148a-3p | CBFA2T2 | -0.75 | 0 | 1.21 | 0 | mirMAP | -0.14 | 8.0E-5 | NA | |
65 | hsa-miR-148a-5p | CBFA2T2 | -0.77 | 0 | 1.21 | 0 | mirMAP | -0.11 | 0.00103 | NA | |
66 | hsa-miR-148a-3p | CBX5 | -0.75 | 0 | 0.35 | 0.00158 | mirMAP | -0.15 | 2.0E-5 | NA | |
67 | hsa-miR-148a-3p | CCDC6 | -0.75 | 0 | 0.05 | 0.48713 | MirTarget | -0.16 | 0 | NA | |
68 | hsa-miR-148a-5p | CCDC6 | -0.77 | 0 | 0.05 | 0.48713 | MirTarget | -0.13 | 0 | NA | |
69 | hsa-miR-148a-3p | CCDC85A | -0.75 | 0 | 0.74 | 9.0E-5 | miRNATAP | -0.16 | 0.00895 | NA | |
70 | hsa-miR-148a-5p | CCDC93 | -0.77 | 0 | 1.03 | 0 | mirMAP | -0.16 | 0 | NA | |
71 | hsa-miR-148a-3p | CCT6A | -0.75 | 0 | 0.81 | 0 | MirTarget | -0.14 | 0 | NA | |
72 | hsa-miR-148a-5p | CD109 | -0.77 | 0 | 1.84 | 0 | mirMAP | -0.35 | 4.0E-5 | NA | |
73 | hsa-miR-148a-5p | CD2AP | -0.77 | 0 | 0.18 | 0.04226 | mirMAP | -0.14 | 0 | NA | |
74 | hsa-miR-148a-5p | CD44 | -0.77 | 0 | -0.09 | 0.71793 | mirMAP | -0.31 | 2.0E-5 | 23861222 | In MHCC97H and MHCC97L cells over-expression of miR-148a blocked the EMT process attenuated the expression of CD90 and CD44 biomarkers for liver cancer stem cells and inhibited their migratory capacity |
75 | hsa-miR-148a-5p | CD93 | -0.77 | 0 | 0.15 | 0.24648 | mirMAP | -0.24 | 0 | NA | |
76 | hsa-miR-148a-3p | CDC25B | -0.75 | 0 | 0.8 | 0 | miRNAWalker2 validate; miRNATAP | -0.29 | 0 | 25341915 | Gene CDC25B might be the target gene of miR-148a according to the results of targetscan; CDC25B may be the target gene of miR-148a that plays a role in tumor suppressor |
77 | hsa-miR-148a-3p | CDK19 | -0.75 | 0 | 0.12 | 0.29406 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.24 | 0 | NA | |
78 | hsa-miR-148a-3p | CDK5R1 | -0.75 | 0 | 1.08 | 0 | MirTarget; miRNATAP | -0.17 | 0.00187 | NA | |
79 | hsa-miR-148a-3p | CDS1 | -0.75 | 0 | -0.32 | 0.40167 | miRNATAP | -0.62 | 0 | NA | |
80 | hsa-miR-148a-5p | CECR6 | -0.77 | 0 | 0.39 | 0.03999 | mirMAP | -0.36 | 0 | NA | |
81 | hsa-miR-148a-3p | CELSR1 | -0.75 | 0 | 0.36 | 0.10713 | MirTarget | -0.21 | 0.00487 | NA | |
82 | hsa-miR-148a-3p | CENPP | -0.75 | 0 | 1.59 | 0 | mirMAP | -0.15 | 0.0069 | NA | |
83 | hsa-miR-148a-3p | CEP55 | -0.75 | 0 | 2.87 | 0 | MirTarget | -0.76 | 0 | NA | |
84 | hsa-miR-148a-3p | CHST1 | -0.75 | 0 | 0.69 | 0.00199 | MirTarget | -0.73 | 0 | NA | |
85 | hsa-miR-148a-3p | CHST3 | -0.75 | 0 | -0.2 | 0.3013 | mirMAP | -0.54 | 0 | NA | |
86 | hsa-miR-148a-3p | CIITA | -0.75 | 0 | 0.27 | 0.18011 | mirMAP | -0.26 | 5.0E-5 | NA | |
87 | hsa-miR-148a-3p | CIT | -0.75 | 0 | 0.47 | 0.00991 | miRNATAP | -0.15 | 0.0119 | NA | |
88 | hsa-miR-148a-3p | CNIH4 | -0.75 | 0 | 1.01 | 0 | MirTarget | -0.1 | 0.00643 | NA | |
89 | hsa-miR-148a-5p | CNIH4 | -0.77 | 0 | 1.01 | 0 | mirMAP | -0.11 | 0.00201 | NA | |
90 | hsa-miR-148a-3p | CNN1 | -0.75 | 0 | 0.41 | 0.09282 | miRNATAP | -0.5 | 0 | NA | |
91 | hsa-miR-148a-5p | CNNM1 | -0.77 | 0 | 0.34 | 0.46754 | MirTarget | -0.48 | 0.00081 | NA | |
92 | hsa-miR-148a-3p | CNTN4 | -0.75 | 0 | -2.24 | 0 | miRNATAP | -0.27 | 0.00181 | NA | |
93 | hsa-miR-148a-3p | COL4A1 | -0.75 | 0 | 1.65 | 0 | miRNATAP | -0.51 | 0 | NA | |
94 | hsa-miR-148a-5p | COL5A2 | -0.77 | 0 | 0.52 | 0.00488 | MirTarget | -0.43 | 0 | NA | |
95 | hsa-miR-148a-3p | CPD | -0.75 | 0 | 0.6 | 0 | MirTarget; miRNATAP | -0.14 | 0.00104 | NA | |
96 | hsa-miR-148a-5p | CPD | -0.77 | 0 | 0.6 | 0 | mirMAP | -0.21 | 0 | NA | |
97 | hsa-miR-148a-3p | CS | -0.75 | 0 | 0.63 | 0 | miRNATAP | -0.15 | 0 | NA | |
98 | hsa-miR-148a-3p | CSF1 | -0.75 | 0 | -0.59 | 0.00153 | miRNATAP | -0.26 | 2.0E-5 | NA | |
99 | hsa-miR-148a-5p | CSNK1E | -0.77 | 0 | 0.61 | 0 | miRNATAP | -0.25 | 0 | NA | |
100 | hsa-miR-148a-5p | CSNK1G1 | -0.77 | 0 | 0.52 | 0 | mirMAP | -0.11 | 1.0E-5 | NA | |
101 | hsa-miR-148a-3p | CSPG4 | -0.75 | 0 | 2.21 | 0 | miRNATAP | -0.47 | 0 | NA | |
102 | hsa-miR-148a-3p | CTTNBP2NL | -0.75 | 0 | 0.03 | 0.8194 | MirTarget; miRNATAP | -0.4 | 0 | NA | |
103 | hsa-miR-148a-5p | CXorf23 | -0.77 | 0 | 0.43 | 1.0E-5 | miRNATAP | -0.11 | 0.00024 | NA | |
104 | hsa-miR-148a-3p | CYTH3 | -0.75 | 0 | 0.61 | 0 | MirTarget; miRNATAP | -0.29 | 0 | NA | |
105 | hsa-miR-148a-5p | CYTIP | -0.77 | 0 | -1.31 | 0 | MirTarget | -0.17 | 0.02059 | NA | |
106 | hsa-miR-148a-5p | DDR1 | -0.77 | 0 | 0.19 | 0.48336 | miRNATAP | -0.67 | 0 | NA | |
107 | hsa-miR-148a-3p | DMPK | -0.75 | 0 | 0.66 | 0 | MirTarget | -0.31 | 0 | NA | |
108 | hsa-miR-148a-3p | DNAJC18 | -0.75 | 0 | 0.38 | 0.00786 | MirTarget | -0.48 | 0 | NA | |
109 | hsa-miR-148a-3p | DNER | -0.75 | 0 | 1.29 | 0.00336 | MirTarget; miRNATAP | -1.04 | 0 | NA | |
110 | hsa-miR-148a-5p | DNM3 | -0.77 | 0 | 1.37 | 0 | mirMAP | -0.18 | 0.0012 | NA | |
111 | hsa-miR-148a-3p | DNMT1 | -0.75 | 0 | 1.07 | 0 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.22 | 0 | 25865490; 26111756; 25950085; 22167392 | miR 148a dependent apoptosis of bladder cancer cells is mediated in part by the epigenetic modifier DNMT1; We additionally show that miR-148a exerts this effect partially by attenuating expression of DNA methyltransferase 1 DNMT1;Moreover we found that miR-148a appeared to be a target of bufalin and miR-148a further regulated DNMT1 and p27 to control the stemness of OS cells;The Interplay Between miR 148a and DNMT1 Might be Exploited for Pancreatic Cancer Therapy; We discovered the expression level of miR-148a significantly decreased in pancreatic cancer tissues whereas that of DNMT1 increased; In ASPC-1 cancer cells the overexpression of miR-148a led to a decreased level of DNMT1 and reduced the proliferation and metastasis of ASPC-1 cells; Interestingly it was shown that the DNMT1 inhibition enhanced the expression of miR-148a; In vivo studies demonstrated that the tumorigenesis of ASPC-1 was significantly arrested by either the overexpression of miR-148a or the inhibition of DNMT1;Studies have shown that microRNA-148a miR-148a was proved to be silenced while DNA methyltransferase 1 DNMT1 was over-expressed in gastric cancer; But the mechanism of aberrant expression of miR-148a and DNMT1 and their relationships in gastric cancer are still unknown; The aims of this study were to investigate the expression profile of miR-148a and DNMT1 and reveal whether they have any relationships; We used reverse-transcriptase quantitative real-time PCR methylation-specific PCR and Western blot to measure the level of miR-148a expression DNA methylation level and DNMT1 expression respectively; DNMT1 was over-expressed in primary tumors and cell lines while knockdown of DNMT1 using siRNA could decrease methylation level of miR-148a promoter and restore its expression; Furthermore ectopic over-expression of miR-148a in cancer cell lines caused reduction in DNMT1 expression and inhibited cell proliferation but no obvious change was found in apoptosis rate; These results suggest that miR-148a is inactivated by DNA hypermethylation of promoter region in gastric cancer which is mediated through DNMT1 over-expression; Additionally the silence of miR-148a reduces its suppression to DNMT1 in gastric cancer and this may in turn result in over-expression of DNMT1 and promote DNA hypermethylation |
112 | hsa-miR-148a-5p | DNMT3A | -0.77 | 0 | 1.19 | 0 | mirMAP | -0.12 | 0.00479 | NA | |
113 | hsa-miR-148a-3p | DNMT3B | -0.75 | 0 | 1.62 | 0 | miRNAWalker2 validate; miRTarBase | -0.19 | 0.00195 | 20841507 | Low ERG expressers presented with down-regulation of genes involved in the DNA-methylation machinery and up-regulation of miR-148a which targets DNMT3B |
114 | hsa-miR-148a-3p | DOCK3 | -0.75 | 0 | 1.9 | 0 | miRNATAP | -0.28 | 0.00024 | NA | |
115 | hsa-miR-148a-3p | DOCK6 | -0.75 | 0 | 0.92 | 0 | MirTarget | -0.24 | 0 | NA | |
116 | hsa-miR-148a-3p | DOT1L | -0.75 | 0 | 0.59 | 0 | mirMAP | -0.11 | 0.0049 | NA | |
117 | hsa-miR-148a-3p | DPP3 | -0.75 | 0 | 0.37 | 1.0E-5 | miRNATAP | -0.13 | 0 | NA | |
118 | hsa-miR-148a-3p | DSTYK | -0.75 | 0 | 1.01 | 0 | miRNAWalker2 validate | -0.2 | 0 | NA | |
119 | hsa-miR-148a-3p | DTNA | -0.75 | 0 | 1.85 | 0 | miRNATAP | -0.42 | 1.0E-5 | NA | |
120 | hsa-miR-148a-5p | DTNA | -0.77 | 0 | 1.85 | 0 | mirMAP | -0.47 | 0 | NA | |
121 | hsa-miR-148a-5p | DTX3 | -0.77 | 0 | 0.08 | 0.67413 | mirMAP | -0.35 | 0 | NA | |
122 | hsa-miR-148a-3p | DYRK1B | -0.75 | 0 | 0.43 | 0.00067 | miRNATAP | -0.23 | 0 | NA | |
123 | hsa-miR-148a-3p | E2F3 | -0.75 | 0 | 0.68 | 0 | miRNATAP | -0.29 | 0 | NA | |
124 | hsa-miR-148a-3p | E2F7 | -0.75 | 0 | 3.07 | 0 | miRNATAP | -0.24 | 0.00995 | NA | |
125 | hsa-miR-148a-5p | ECT2 | -0.77 | 0 | 2.35 | 0 | miRNATAP | -0.32 | 0 | NA | |
126 | hsa-miR-148a-5p | EDA | -0.77 | 0 | -0.45 | 0.10078 | mirMAP | -0.5 | 0 | NA | |
127 | hsa-miR-148a-5p | EDNRA | -0.77 | 0 | -0.02 | 0.89416 | mirMAP | -0.46 | 0 | NA | |
128 | hsa-miR-148a-5p | EFHC1 | -0.77 | 0 | 0.85 | 0 | mirMAP | -0.23 | 0 | NA | |
129 | hsa-miR-148a-3p | EFNB2 | -0.75 | 0 | 0.1 | 0.47703 | MirTarget; miRNATAP | -0.19 | 4.0E-5 | NA | |
130 | hsa-miR-148a-3p | EGR3 | -0.75 | 0 | -2.49 | 0 | MirTarget | -0.21 | 0.01299 | NA | |
131 | hsa-miR-148a-3p | ELFN2 | -0.75 | 0 | 2.87 | 0 | mirMAP | -0.48 | 0.00248 | NA | |
132 | hsa-miR-148a-5p | ELK3 | -0.77 | 0 | -0.37 | 0.06773 | MirTarget | -0.21 | 0.00069 | NA | |
133 | hsa-miR-148a-5p | ENAH | -0.77 | 0 | 1.4 | 0 | mirMAP | -0.28 | 0 | NA | |
134 | hsa-miR-148a-3p | ENTPD1 | -0.75 | 0 | 0.55 | 0 | mirMAP | -0.3 | 0 | NA | |
135 | hsa-miR-148a-5p | ENTPD1 | -0.77 | 0 | 0.55 | 0 | mirMAP | -0.24 | 0 | NA | |
136 | hsa-miR-148a-3p | EPB41L1 | -0.75 | 0 | 0.13 | 0.60566 | MirTarget | -0.3 | 0.00034 | NA | |
137 | hsa-miR-148a-5p | EPCAM | -0.77 | 0 | -1.91 | 0.00205 | miRNATAP | -1.19 | 0 | NA | |
138 | hsa-miR-148a-5p | EPHA3 | -0.77 | 0 | -1.76 | 0 | mirMAP | -0.54 | 0 | NA | |
139 | hsa-miR-148a-3p | EPN2 | -0.75 | 0 | 0.04 | 0.69334 | MirTarget; miRNATAP | -0.12 | 6.0E-5 | NA | |
140 | hsa-miR-148a-3p | ERC2 | -0.75 | 0 | 1.32 | 2.0E-5 | MirTarget | -0.31 | 0.00232 | NA | |
141 | hsa-miR-148a-3p | ERMP1 | -0.75 | 0 | 0.54 | 1.0E-5 | MirTarget | -0.26 | 0 | NA | |
142 | hsa-miR-148a-3p | ETV5 | -0.75 | 0 | -0.15 | 0.35537 | MirTarget; miRNATAP | -0.3 | 0 | NA | |
143 | hsa-miR-148a-5p | EXT1 | -0.77 | 0 | -0.12 | 0.33701 | mirMAP | -0.25 | 0 | NA | |
144 | hsa-miR-148a-3p | F3 | -0.75 | 0 | -1.78 | 0 | MirTarget | -0.59 | 0 | NA | |
145 | hsa-miR-148a-5p | FAM102B | -0.77 | 0 | -0.16 | 0.25601 | MirTarget | -0.29 | 0 | NA | |
146 | hsa-miR-148a-5p | FAM117B | -0.77 | 0 | 0.1 | 0.44264 | MirTarget | -0.28 | 0 | NA | |
147 | hsa-miR-148a-3p | FAM160B2 | -0.75 | 0 | 0.17 | 0.05405 | mirMAP | -0.16 | 0 | NA | |
148 | hsa-miR-148a-3p | FAM53B | -0.75 | 0 | 0.97 | 0 | mirMAP | -0.29 | 0 | NA | |
149 | hsa-miR-148a-3p | FBXL19 | -0.75 | 0 | 1.09 | 0 | miRNATAP | -0.38 | 0 | NA | |
150 | hsa-miR-148a-5p | FBXO41 | -0.77 | 0 | 0.4 | 0.10243 | mirMAP | -0.45 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | NEUROGENESIS | 77 | 1402 | 2.025e-14 | 9.424e-11 |
2 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 84 | 1672 | 1.537e-13 | 2.766e-10 |
3 | REGULATION OF CELL DIFFERENTIATION | 78 | 1492 | 1.784e-13 | 2.766e-10 |
4 | CELL DEVELOPMENT | 74 | 1426 | 1.209e-12 | 1.406e-09 |
5 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 57 | 957 | 3.233e-12 | 3.008e-09 |
6 | TISSUE DEVELOPMENT | 75 | 1518 | 9.072e-12 | 7.036e-09 |
7 | NEURON PROJECTION DEVELOPMENT | 39 | 545 | 5.885e-11 | 3.912e-08 |
8 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 65 | 1275 | 7.55e-11 | 4.391e-08 |
9 | NEURON DIFFERENTIATION | 51 | 874 | 1.048e-10 | 5.419e-08 |
10 | TISSUE MORPHOGENESIS | 38 | 533 | 1.17e-10 | 5.442e-08 |
11 | MORPHOGENESIS OF AN EPITHELIUM | 32 | 400 | 2.08e-10 | 8.405e-08 |
12 | REGULATION OF CELL DEVELOPMENT | 49 | 836 | 2.168e-10 | 8.405e-08 |
13 | NEURON PROJECTION MORPHOGENESIS | 32 | 402 | 2.361e-10 | 8.451e-08 |
14 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 54 | 1021 | 1.02e-09 | 3.389e-07 |
15 | REGULATION OF NEURON DIFFERENTIATION | 37 | 554 | 1.273e-09 | 3.947e-07 |
16 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 44 | 750 | 1.891e-09 | 5.5e-07 |
17 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 29 | 368 | 2.125e-09 | 5.815e-07 |
18 | CELLULAR COMPONENT MORPHOGENESIS | 49 | 900 | 2.556e-09 | 6.25e-07 |
19 | CELL PROJECTION ORGANIZATION | 49 | 902 | 2.748e-09 | 6.25e-07 |
20 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 45 | 788 | 2.821e-09 | 6.25e-07 |
21 | CIRCULATORY SYSTEM DEVELOPMENT | 45 | 788 | 2.821e-09 | 6.25e-07 |
22 | NEURON PROJECTION GUIDANCE | 21 | 205 | 3.88e-09 | 8.206e-07 |
23 | EPITHELIUM DEVELOPMENT | 50 | 945 | 4.463e-09 | 9.029e-07 |
24 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 56 | 1142 | 7.355e-09 | 1.426e-06 |
25 | NEURON DEVELOPMENT | 40 | 687 | 1.332e-08 | 2.478e-06 |
26 | LOCOMOTION | 54 | 1114 | 2.076e-08 | 3.716e-06 |
27 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 33 | 513 | 2.558e-08 | 4.408e-06 |
28 | CELL PART MORPHOGENESIS | 37 | 633 | 4.342e-08 | 7.216e-06 |
29 | BIOLOGICAL ADHESION | 50 | 1032 | 7.426e-08 | 1.192e-05 |
30 | PROTEIN PHOSPHORYLATION | 47 | 944 | 8.505e-08 | 1.319e-05 |
31 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 61 | 1395 | 9.722e-08 | 1.459e-05 |
32 | TUBE DEVELOPMENT | 33 | 552 | 1.432e-07 | 2.082e-05 |
33 | TUBE MORPHOGENESIS | 24 | 323 | 1.6e-07 | 2.19e-05 |
34 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 44 | 872 | 1.564e-07 | 2.19e-05 |
35 | ACTIN FILAMENT BASED PROCESS | 29 | 450 | 1.768e-07 | 2.351e-05 |
36 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 42 | 823 | 2.254e-07 | 2.913e-05 |
37 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 23 | 306 | 2.368e-07 | 2.978e-05 |
38 | REGULATION OF CELL ADHESION | 35 | 629 | 3.31e-07 | 4.054e-05 |
39 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 24 | 337 | 3.485e-07 | 4.158e-05 |
40 | BLOOD VESSEL MORPHOGENESIS | 25 | 364 | 3.918e-07 | 4.558e-05 |
41 | POSITIVE REGULATION OF CELL DEVELOPMENT | 29 | 472 | 4.77e-07 | 5.414e-05 |
42 | CELL MOTILITY | 41 | 835 | 8.589e-07 | 9.294e-05 |
43 | LOCALIZATION OF CELL | 41 | 835 | 8.589e-07 | 9.294e-05 |
44 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 27 | 437 | 1.071e-06 | 0.0001133 |
45 | VASCULATURE DEVELOPMENT | 28 | 469 | 1.328e-06 | 0.0001373 |
46 | ANGIOGENESIS | 21 | 293 | 1.708e-06 | 0.0001728 |
47 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 25 | 408 | 3.12e-06 | 0.0003024 |
48 | EXTRACELLULAR STRUCTURE ORGANIZATION | 21 | 304 | 3.062e-06 | 0.0003024 |
49 | REGULATION OF CELL MORPHOGENESIS | 30 | 552 | 3.765e-06 | 0.0003576 |
50 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 20 | 285 | 4.149e-06 | 0.0003861 |
51 | HEAD DEVELOPMENT | 35 | 709 | 5.012e-06 | 0.0004573 |
52 | NEURON RECOGNITION | 7 | 33 | 5.41e-06 | 0.000484 |
53 | ORGAN MORPHOGENESIS | 39 | 841 | 6.27e-06 | 0.0005505 |
54 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 34 | 689 | 6.922e-06 | 0.0005964 |
55 | MUSCLE STRUCTURE DEVELOPMENT | 25 | 432 | 8.451e-06 | 0.000715 |
56 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 36 | 771 | 1.245e-05 | 0.001035 |
57 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 62 | 1656 | 1.317e-05 | 0.001075 |
58 | SYNAPSE ORGANIZATION | 13 | 145 | 1.588e-05 | 0.001274 |
59 | AGING | 18 | 264 | 1.846e-05 | 0.001456 |
60 | PHOSPHORYLATION | 49 | 1228 | 2.372e-05 | 0.00184 |
61 | NEURON MIGRATION | 11 | 110 | 2.577e-05 | 0.001966 |
62 | BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 12 | 131 | 2.706e-05 | 0.002031 |
63 | SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 21 | 352 | 2.847e-05 | 0.002079 |
64 | REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 10 | 92 | 2.904e-05 | 0.002079 |
65 | UROGENITAL SYSTEM DEVELOPMENT | 19 | 299 | 2.899e-05 | 0.002079 |
66 | HEART DEVELOPMENT | 25 | 466 | 3.021e-05 | 0.00213 |
67 | REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 9 | 75 | 3.292e-05 | 0.002286 |
68 | REGULATION OF CELL PROJECTION ORGANIZATION | 28 | 558 | 3.377e-05 | 0.002311 |
69 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 64 | 1784 | 3.504e-05 | 0.002363 |
70 | REGULATION OF CELL PROLIFERATION | 56 | 1496 | 3.641e-05 | 0.002421 |
71 | AXONAL FASCICULATION | 5 | 20 | 5.389e-05 | 0.003531 |
72 | EMBRYO DEVELOPMENT | 38 | 894 | 5.572e-05 | 0.003601 |
73 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 68 | 1977 | 7.151e-05 | 0.004558 |
74 | INTRACELLULAR SIGNAL TRANSDUCTION | 57 | 1572 | 7.408e-05 | 0.004621 |
75 | REGULATION OF AXONOGENESIS | 13 | 168 | 7.449e-05 | 0.004621 |
76 | TAXIS | 24 | 464 | 7.695e-05 | 0.004653 |
77 | REGULATION OF CALCIUM ION IMPORT | 10 | 103 | 7.701e-05 | 0.004653 |
78 | TISSUE MIGRATION | 9 | 84 | 8.136e-05 | 0.004853 |
79 | CONNECTIVE TISSUE DEVELOPMENT | 14 | 194 | 8.477e-05 | 0.004993 |
80 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 40 | 983 | 9.13e-05 | 0.00531 |
81 | REGULATION OF SEQUESTERING OF CALCIUM ION | 10 | 107 | 0.0001063 | 0.005958 |
82 | AMINOGLYCAN BIOSYNTHETIC PROCESS | 10 | 107 | 0.0001063 | 0.005958 |
83 | NEGATIVE REGULATION OF CELL ADHESION | 15 | 223 | 0.0001057 | 0.005958 |
84 | MUCOPOLYSACCHARIDE METABOLIC PROCESS | 10 | 108 | 0.0001149 | 0.006365 |
85 | NEGATIVE REGULATION OF GENE EXPRESSION | 54 | 1493 | 0.0001243 | 0.006803 |
86 | REGULATION OF CELL GROWTH | 21 | 391 | 0.0001276 | 0.006903 |
87 | REGULATION OF OSSIFICATION | 13 | 178 | 0.0001338 | 0.007154 |
88 | CELL CELL SIGNALING | 33 | 767 | 0.0001384 | 0.007318 |
89 | SKIN EPIDERMIS DEVELOPMENT | 8 | 71 | 0.0001415 | 0.007396 |
90 | SYNAPTIC SIGNALING | 22 | 424 | 0.0001454 | 0.007518 |
91 | CYTOSKELETON ORGANIZATION | 35 | 838 | 0.0001544 | 0.007896 |
92 | REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM | 5 | 25 | 0.000169 | 0.008546 |
93 | REGULATION OF CATION TRANSMEMBRANE TRANSPORT | 14 | 208 | 0.0001771 | 0.00886 |
94 | REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 13 | 184 | 0.000186 | 0.009209 |
95 | NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 10 | 115 | 0.0001936 | 0.009431 |
96 | ACTION POTENTIAL | 9 | 94 | 0.0001946 | 0.009431 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | PROTEIN KINASE ACTIVITY | 32 | 640 | 9.966e-06 | 0.004629 |
2 | SH3 DOMAIN BINDING | 12 | 116 | 7.842e-06 | 0.004629 |
3 | CYTOSKELETAL PROTEIN BINDING | 37 | 819 | 1.935e-05 | 0.005993 |
4 | PROTEIN DOMAIN SPECIFIC BINDING | 30 | 624 | 3.932e-05 | 0.009132 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CELL JUNCTION | 58 | 1151 | 1.406e-09 | 8.214e-07 |
2 | ANCHORING JUNCTION | 29 | 489 | 9.806e-07 | 0.0002863 |
3 | CONTRACTILE FIBER | 17 | 211 | 3.515e-06 | 0.0006843 |
4 | CYTOSKELETON | 72 | 1967 | 5.216e-06 | 0.0007526 |
5 | CELL SUBSTRATE JUNCTION | 24 | 398 | 6.444e-06 | 0.0007526 |
6 | I BAND | 12 | 121 | 1.211e-05 | 0.001179 |
7 | CELL PROJECTION | 65 | 1786 | 1.935e-05 | 0.001614 |
8 | NEURON PROJECTION | 40 | 942 | 3.612e-05 | 0.002344 |
9 | CELL CELL JUNCTION | 22 | 383 | 3.28e-05 | 0.002344 |
10 | AXON | 23 | 418 | 4.253e-05 | 0.002484 |
11 | CELL SURFACE | 34 | 757 | 4.761e-05 | 0.002528 |
12 | NEURON PART | 47 | 1265 | 0.0001916 | 0.009324 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | TGF_beta_signaling_pathway_hsa04350 | 6 | 84 | 0.009577 | 0.1589 | |
2 | Ferroptosis_hsa04216 | 4 | 40 | 0.01054 | 0.1589 | |
3 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 8 | 139 | 0.01061 | 0.1589 | |
4 | Ras_signaling_pathway_hsa04014 | 11 | 232 | 0.01222 | 0.1589 | |
5 | Hedgehog_signaling_pathway_hsa04340 | 4 | 47 | 0.01829 | 0.1618 | |
6 | Hippo_signaling_pathway_hsa04390 | 8 | 154 | 0.01867 | 0.1618 | |
7 | Hippo_signaling_pathway_multiple_species_hsa04392 | 3 | 29 | 0.02398 | 0.1782 | |
8 | cGMP_PKG_signaling_pathway_hsa04022 | 7 | 163 | 0.06338 | 0.317 | |
9 | HIF_1_signaling_pathway_hsa04066 | 5 | 100 | 0.06514 | 0.317 | |
10 | cAMP_signaling_pathway_hsa04024 | 8 | 198 | 0.06554 | 0.317 | |
11 | Focal_adhesion_hsa04510 | 8 | 199 | 0.06707 | 0.317 | |
12 | Cell_adhesion_molecules_.CAMs._hsa04514 | 6 | 145 | 0.09403 | 0.347 | |
13 | Wnt_signaling_pathway_hsa04310 | 6 | 146 | 0.09639 | 0.347 | |
14 | Calcium_signaling_pathway_hsa04020 | 7 | 182 | 0.09949 | 0.347 | |
15 | ECM_receptor_interaction_hsa04512 | 4 | 82 | 0.101 | 0.347 | |
16 | MAPK_signaling_pathway_hsa04010 | 10 | 295 | 0.1068 | 0.347 | |
17 | Endocytosis_hsa04144 | 8 | 244 | 0.1583 | 0.4476 | |
18 | Tight_junction_hsa04530 | 6 | 170 | 0.1618 | 0.4476 | |
19 | Regulation_of_actin_cytoskeleton_hsa04810 | 7 | 208 | 0.1636 | 0.4476 | |
20 | Adherens_junction_hsa04520 | 3 | 72 | 0.2027 | 0.5142 | |
21 | Phospholipase_D_signaling_pathway_hsa04072 | 5 | 146 | 0.2077 | 0.5142 | |
22 | PI3K_Akt_signaling_pathway_hsa04151 | 10 | 352 | 0.2302 | 0.544 | |
23 | ABC_transporters_hsa02010 | 2 | 45 | 0.253 | 0.5719 | |
24 | Notch_signaling_pathway_hsa04330 | 2 | 48 | 0.277 | 0.5798 | |
25 | Cell_cycle_hsa04110 | 4 | 124 | 0.2787 | 0.5798 | |
26 | FoxO_signaling_pathway_hsa04068 | 4 | 132 | 0.3175 | 0.635 | |
27 | Mitophagy_animal_hsa04137 | 2 | 65 | 0.4101 | 0.771 | |
28 | Phagosome_hsa04145 | 4 | 152 | 0.4151 | 0.771 | |
29 | Cellular_senescence_hsa04218 | 4 | 160 | 0.4535 | 0.813 | |
30 | Sphingolipid_signaling_pathway_hsa04071 | 3 | 118 | 0.469 | 0.813 | |
31 | Autophagy_animal_hsa04140 | 3 | 128 | 0.5231 | 0.8221 | |
32 | ErbB_signaling_pathway_hsa04012 | 2 | 85 | 0.5497 | 0.8221 | |
33 | Gap_junction_hsa04540 | 2 | 88 | 0.5686 | 0.8221 | |
34 | Apelin_signaling_pathway_hsa04371 | 3 | 137 | 0.5691 | 0.8221 | |
35 | Rap1_signaling_pathway_hsa04015 | 4 | 206 | 0.6513 | 0.9154 | |
36 | TNF_signaling_pathway_hsa04668 | 2 | 108 | 0.6795 | 0.926 | |
37 | Cytokine_cytokine_receptor_interaction_hsa04060 | 5 | 270 | 0.6945 | 0.926 | |
38 | AMPK_signaling_pathway_hsa04152 | 2 | 121 | 0.7384 | 0.9391 | |
39 | Oocyte_meiosis_hsa04114 | 2 | 124 | 0.7506 | 0.9391 | |
40 | Apoptosis_hsa04210 | 2 | 138 | 0.8012 | 0.9391 | |
41 | mTOR_signaling_pathway_hsa04150 | 2 | 151 | 0.8399 | 0.9391 | |
42 | Jak_STAT_signaling_pathway_hsa04630 | 2 | 162 | 0.8671 | 0.9391 | |
43 | Necroptosis_hsa04217 | 2 | 164 | 0.8716 | 0.9391 | |
44 | Neuroactive_ligand_receptor_interaction_hsa04080 | 3 | 278 | 0.9408 | 0.9592 |